text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "natural"
Too many choices? Use the filter option on the left to narrow your product listing.
21-30 of 48 results
1-10 of 484 results
  • Natural Killer Cells Infographic
    Natural Killer cells have an innate ability to recognize and destroy non-self cells.
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • 3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
    Watch Video
  • Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity Assay
    Protocol instructions
  • Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • White Paper - PyroGene® Recombinant Factor C Assay – Endotoxin Testing: It's Time to Embrace the 'Alternative'
    This white paper addresses topics such as: the growing demand of a natural resource, benefits of the synthetic version of Factor C and how to validate the PyroGene® rFC Assay.
  • An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
    A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
  • Amazon Gift Card Giveaway T&Cs
    Terms and conditions for neural survey giveaway
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.